Австралія - англійська - Department of Health (Therapeutic Goods Administration)

draeger australia pty ltd - 14361 - ventilator, neonatal/paediatric - the babylog vn500 ventilation unit of the infinity acute care system is intended for the ventilation of neonatal and paediatric patients. babylog vn500 offers mandatory ventilation modes and ventilation modes for spontaneous breathing support and airway monitoring. the babylog vn500 ventilation unit is used with infinity c series drager medical cockpits. the babylog vn500 ventilation unit is intended for use in different medical care areas for patients neeeding respiratory support for different medical reasons temporarily or for long term periods of time.

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

biomedical solutions - 14361 - ventilator, neonatal/paediatric - a dedicated automatic cycling device used to control and assist alveolar ventilation, with sufficient functions to provide long-term ventilatory support for neonatal/paediatric patients with varying respiratory demands. the design of the device will make it especially favourible for ventilation of premature newborn and unsuitable for use on children or adults. it will typically have pressure cycled modes and allow for spontaneous breathing while providing for a minimum minute volume in the event of patient apnoea. it will have monitors and alarms specifically designed this intensive care setting.

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

vyaire medical pty ltd - 14361 - ventilator, neonatal/paediatric - a device providing automatic cycling used to assist/control alveolar ventilation by delivering an appropriate volume of gas to the respiratory airways. respiratory gases are delivered to the patient's airway through a mouthpiece, mask, or endotracheal tube. the device provides respiratory support to neonates and paediatric patients in intensive care units and for transport and includes high frequency oscillation and the delivery of nitric oxide and other special applications that pertain to specific clinical conditions. the device is used with breathing circuits and may be used with airway monitoring devices.

Філіппіни - англійська - FDA (Food And Drug Administration)

getz pharma (phils.), inc.; distributor: getz pharma (phils.), inc. - montelukast (as sodium) - pediatric granules - 4mg

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 58703 - neonatal/paediatric heart rate monitoring application software - hero is intended to acquire, store, analyze, and report on ecg data collected from infants. hero is intended to be used by trained operators under the direct supervision of a licensed health care practitioner in a hospital neonatal or pediatric icu environment. hero is intended to be used for the analysis of the variability in rr intervals (heart rate) and to report measurements of the variability of heart rate data (hrv). the hrv measurements reported by hero are specialized in nature, and intended to identify periods of transient decelerations and/or reduced baseline variability in the heart rate. hero is intended to provide specialized hrv measurements and may detect arrhythmias, that when combined with other risk factors, can be used as an aid in assessing the risk of sepsis in infants. the use of the hero monitoring improves survival in very low birth weight neonates.

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

apl group pty ltd - 41587 - external defibrillator electrode, paediatric, single use - the defibrillator electrode pad transmits an electric shock from an external defibrillator to the patient (paediatric, single use).

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

getinge australia pty ltd - 14361 - ventilator, neonatal/paediatric - the ventilator system is intended for respiratory support, monitoring and treatment of neonatal and pediatric patients.

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxicillin trihydrate, quantity: 116.96 mg/ml (equivalent: amoxicillin, qty 100 mg/ml) - oral liquid, powder for - excipient ingredients: crospovidone; xanthan gum; sodium benzoate; hydrophobic colloidal silica anhydrous; magnesium stearate; aspartame; carmellose sodium; flavour - it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms: note therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e.coli (see microbiology). respiratory (acute and chronic): h.influenzae, streptococcus; s.pneumoniae; staphylococcus, non-penicillinase-producing; e.coli (see microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see microbiology), p.mirabilis and s.faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxil may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.

США - англійська - NLM (National Library of Medicine)

rising pharma holdings, inc. - clindamycin palmitate hydrochloride (unii: vn9a8jm7m7) (clindamycin - unii:3u02el437c) - clindamycin 75 mg in 5 ml - clindamycin palmitate hydrochloride for oral solution, usp (pediatric) (clindamycin palmitate hcl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of colitis, as described in the boxed warning , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). anaerobes: serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastroi

США - англійська - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - zinc cation 4.39 mg in 1 ml - this formulation is indicated for use as a supplement to intravenous solutions given for tpn for children up to 11 years of age. administration of the solution in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. multitrace ® - 4 pediatric should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.